fashion -WSS

fashion

author：hotspot 2025-10-01 05:39:07 - browse：6

Three boxes of Breyanzi on a dark blue background — biotech coverage from STAT — The FDA is looking into adverse events involving a number of CAR-T therapies, including Breyanzi. Illustration: STAT; Source: Business Wire

The Food and Drug Administration said Tuesday that it is investigating whether CAR-T therapy, which uses genetically modified white blood cells to attack tumors, can in rare cases cause lymphoma, a blood cancer.

“Although the overall benefits of these products continue to outweigh their potential risks for their approved uses, FDA is investigating the identified risk of T cell malignancy with serious outcomes, including hospitalization and death, and is evaluating the need for regulatory action,” the agency said in a statement.

The agency noted that it is investigating reports of T cell lymphoma, including cancer cells carrying the engineered T cells, in patients who received CAR-T therapy. Experts in the field, which has produced multiple approved products to treat blood cancer, expressed surprise and puzzlement at the announcement, saying that they had not previously seen data about the risk.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Sage hopes for a blockbuster in antidepressant now before FDA

focus

WSS

Humana sues Biden admin over Medicare Advantage audit rule

Ethical issues complicate the benefits of medical crowdfunding

5 important ways Henrietta Lacks changed medical science

Micronoma's microbiome cancer diagnostic approach under fire

ALS advocates say criticism of new drugs misses bigger picture

Amazon on where the company's health care bets are headed next

explore

fashion

knowledge

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Lawsuit alleges UnitedHealth Group unit illegally denied claims

Continuity nursing helped my family in our darkest PICU moments

Stem cell treatment guidelines are released by FDA

As demand for Covid shots wanes, Moderna seeks its next success

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

George Santos makes 1st court appearance after pleading not guilty to 13 counts

What the airline industry can learn from medicine

The cancer drug shortage isn’t new — and neither are the solutions

Pence says 'crackpot lawyers' told Trump what he wanted to hear

hotspot

Humana sues Biden admin over Medicare Advantage audit rule

Physician groups backed by private equity giant lobby on mergers

Physician groups backed by private equity giant lobby on mergers

What the airline industry can learn from medicine

AstraZeneca chief proposes a novel edit to the drug pricing bill

Why Novartis is changing the name of its research labs

hotspot

focus

focus

hotspot